Sponsor:
Fertility Center of Las Vegas
Code:
NCT06133803
Conditions
Infertility, Female
Eligibility Criteria
Sex: Female
Age: 18 - 42
Healthy Volunteers: Accepted
Interventions
Lovenox
Aspirin
Embryo transfer
Brief summary:
Conditions
Infertility, Female
Study ID
NCT06133803
Start date
Jan 26, 2024
Status verified date
Nov, 2023
Completion date
Dec 15, 2024
Anticipated
Primary completion date
Dec 15, 2024
Anticipated
Eligibility Criteria
Sex: Female
Age: 18 - 42
Healthy Volunteers: Accepted
Enrollment
130 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Treatment Arm
active comparator: Control Arm
Interventions
Lovenox
Aspirin
Embryo transfer
Primary outcome measure
Central contacts
Locations
Fertility center of Las Vegas
Recruiting
Las Vegas, Nevada, United States, 89117
Contacts
Sponsor
Fertility Center of Las Vegas
Last update posted
Feb 21, 2024
Last verified
Nov, 2023
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Fertility Center of Las Vegas on 2024-02-21.